What is the significance of TP53 accumulation in anal squamous carcinoma?

被引：0
|
作者：
Patel, HS
Northover, JM
Silver, A
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2006年 / 49卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：779 / 780
页数：2
相关论文
共 50 条
  • [41] Utility of TP53 in Breast Carcinoma Immunophenotypes
    Jaggi, Ria
    Shukla, Samarth
    Acharya, Sourya
    Vagha, Sunita
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (09)
  • [42] TP53 overexpression in recurrent endometrial carcinoma
    Pijnenborg, JMA
    van de Broek, L
    de Veen, GCD
    Roemen, GMJM
    de Haan, J
    van Engeland, M
    Voncken, JW
    Groothuis, PG
    GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 397 - 404
  • [43] Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
    Loeb, Keith R.
    Asgari, Maryam M.
    Hawes, Stephen E.
    Feng, Qinghua
    Stern, Joshua E.
    Jiang, Mingjun
    Argenyi, Zsolt B.
    de Villiers, Ethel-Michele
    Kiviat, Nancy B.
    PLOS ONE, 2012, 7 (04):
  • [44] TP53 Wild-Type, Human Papillomavirus-Independent Anal Growth/(Intra)Epithelial Lesion (ANGEL): A Potential Precursor of Anal Squamous Cell Carcinoma
    Pinto, Andre
    Singhi, Aatur D.
    Voltaggio, Lysandra
    Salimian, Kevan
    Birkness-Gartman, Jacqueline
    Montgomery, Elizabeth A.
    MODERN PATHOLOGY, 2025, 38 (05)
  • [45] Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck
    Chen, Kexin
    Hu, Zhibin
    Wang, Li-E
    Zhang, Wei
    Ei-Naggar, Adel K.
    Sturgis, Erich M.
    Wei, Qingyi
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4300 - 4305
  • [46] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [47] Development of TP53 targeted treatment strategy in esophageal squamous cell carcinoma based on clinical information, TP53 mutation status and p53 RNA expression level
    Kamata, Toshiki
    Kano, Masayuki
    Takahashi, Masahiko
    Murakami, Kentaro
    Sakata, Haruhito
    Endo, Satoshi
    Toyozumi, Takeshi
    Matsumoto, Yasunori
    Suito, Hiroshi
    Yokoyama, Masaya
    Okada, Kouichiro
    Shiraishi, Tadashi
    Ryuzaki, Takahiro
    Kinoshita, Kazuya
    Hirasawa, Souichiro
    Matsubara, Hisahiro
    CANCER RESEARCH, 2020, 80 (16)
  • [48] TP53 genetic heterogeneity in recurrent or second primary head and neck squamous cell carcinoma
    Kampel, Liyona
    Feldstein, Sara
    Tsuriel, Shlomo
    Trejo, Leonor Leider
    Horowitz, Gilad
    Warshavsky, Anton
    Mansour, Jobran
    Hershkovitz, Dov
    Muhanna, Nidal
    RADIOTHERAPY AND ONCOLOGY, 2025, 204
  • [49] Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection
    Eicheler, W
    Zips, D
    Dörfler, A
    Grénman, R
    Baumann, M
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (02) : 197 - 204
  • [50] TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma
    van Kempen, Pauline M. W.
    Verdam, Froukje J.
    de Poel, Eyleen
    Braunius, Weibel W.
    de Weger, Roel A.
    van Es, Robert J. J.
    Grolman, Wilko
    Willems, Stefan M.
    PATHOBIOLOGY, 2015, 82 (01) : 21 - 27
12345